journal article·2024-12-11

Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis Efficacy

Zhaoxia Cheng, Fenfen Li, Yunkai Qie, Jingyi Sun, Yazhou Wang, Ying Zhao, Guangjun Nie

Nano Letters· Volume 24· Issue 49
Publisher page

Abstract

Liver fibrosis is characterized by the excessive accumulation of extracellular matrix proteins primarily produced by activated hepatic stellate cells (HSCs). The activation of HSCs plays a pivotal role in driving the progression of liver fibrosis. Achieving specific targeted delivery of antifibrotic agents toward activated HSCs remains a formidable challenge. Here, we developed an HSC membrane-camouflaged nanosystem, named HSC-PLGA-BAY, for the precise delivery of the antifibrosis agent BAY 11-7082 to activated HSCs in the treatment of liver fibrosis. The designed HSC-PLGA-BAY nanosystem exhibited selective targeting toward activated HSCs, with internalization mediated by homologous cell adhesion molecules from the HSC membrane, namely integrins and N-cadherin. Furthermore, our findings demonstrate that treatment with HSC-PGA-BAY significantly increased apoptosis of activated HSCs and ameliorated liver fibrosis progression in a bile duct ligation (BDL)-induced fibrotic mice model. Collectively, the HSCs-targeted therapeutic platform holds promising potential as an effective strategy for liver fibrosis treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Genetic and Kidney Cyst Diseases · Liver Disease Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry, Zhengzhou University, Zhengzhou 450001, China

CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China

Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China

Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Funding

Youth Innovation Promotion Association of the Chinese Academy of Sciences · Natural Science Foundation of Beijing Municipality · China Academy of Chinese Medical Sciences · National Natural Science Foundation of China · Beijing Nova Program · National Science and Technology Major Project

References (51)

Show source-provided references
1. 10.1172/JCI2428210.1172/JCI24282 ↗
2. 10.1016/j.jhep.2015.03.03910.1016/j.jhep.2015.03.039 ↗
3. 10.1016/j.jhep.2017.11.01210.1016/j.jhep.2017.11.012 ↗
4. 10.1038/ncomms382310.1038/ncomms3823 ↗
5. 10.1016/j.addr.2017.11.00810.1016/j.addr.2017.11.008 ↗
6. 10.1073/pnas.120184010910.1073/pnas.1201840109 ↗
7. 10.1016/j.jhep.2019.04.01210.1016/j.jhep.2019.04.012 ↗
8. 10.1002/hep.3174310.1002/hep.31743 ↗
9. 10.1038/nrgastro.2017.3810.1038/nrgastro.2017.38 ↗
10. 10.1097/HEP.000000000000032610.1097/HEP.0000000000000326 ↗
11. 10.1136/gutjnl-2019-31837210.1136/gutjnl-2019-318372 ↗
12. 10.1038/nrgastro.2010.21310.1038/nrgastro.2010.213 ↗
13. 10.1152/ajpgi.00185.200710.1152/ajpgi.00185.2007 ↗
14. 10.1038/nrgastro.2010.9710.1038/nrgastro.2010.97 ↗
15. 10.1053/j.gastro.2004.10.00310.1053/j.gastro.2004.10.003 ↗
16. 10.1002/hep.2103610.1002/hep.21036 ↗
17. 10.1002/adma.20221220610.1002/adma.202212206 ↗
18. 10.1021/acsnano.3c0610710.1021/acsnano.3c06107 ↗
19. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
20. 10.1038/nmat464410.1038/nmat4644 ↗
21. 10.1038/s41565-024-01687-110.1038/s41565-024-01687-1 ↗
22. 10.1016/j.chempr.2020.06.00210.1016/j.chempr.2020.06.002 ↗
23. 10.1021/acsnano.7b0771610.1021/acsnano.7b07716 ↗
24. 10.1126/sciadv.aay903510.1126/sciadv.aay9035 ↗
25. 10.1002/adma.20220892310.1002/adma.202208923 ↗
26. 10.1021/acsnano.4c0481410.1021/acsnano.4c04814 ↗
27. 10.1016/j.addr.2018.06.01210.1016/j.addr.2018.06.012 ↗
28. 10.1002/adma.20180402310.1002/adma.201804023 ↗
29. 10.1002/adma.20220978510.1002/adma.202209785 ↗
30. 10.1038/s41565-023-01498-w10.1038/s41565-023-01498-w ↗
31. 10.1002/adma.20190079510.1002/adma.201900795 ↗
32. 10.1021/acs.nanolett.9b0381710.1021/acs.nanolett.9b03817 ↗
33. 10.1002/adma.20231044310.1002/adma.202310443 ↗
34. 10.1073/pnas.171426711410.1073/pnas.1714267114 ↗
35. 10.1126/scitranslmed.abc281610.1126/scitranslmed.abc2816 ↗
36. 10.1016/j.biomaterials.2011.07.03210.1016/j.biomaterials.2011.07.032 ↗
37. 10.1038/nprot.2015.01710.1038/nprot.2015.017 ↗
38. 10.1021/acsnano.6b0469510.1021/acsnano.6b04695 ↗
39. 10.1021/acsnano.8b0406610.1021/acsnano.8b04066 ↗
40. 10.3390/cells812150310.3390/cells8121503 ↗
41. 10.1021/acs.nanolett.0c0150310.1021/acs.nanolett.0c01503 ↗
42. 10.1002/hep.2446710.1002/hep.24467 ↗
43. 10.1016/j.jconrel.2023.01.05210.1016/j.jconrel.2023.01.052 ↗
44. 10.1016/j.biomaterials.2023.12223210.1016/j.biomaterials.2023.122232 ↗
45. 10.1016/S0168-8278(00)80159-210.1016/S0168-8278(00)80159-2 ↗
46. 10.1126/sciimmunol.aal306210.1126/sciimmunol.aal3062 ↗
47. 10.1016/S2468-1253(16)30110-810.1016/S2468-1253(16)30110-8 ↗
48. 10.1016/j.addr.2017.05.00710.1016/j.addr.2017.05.007 ↗
49. 10.1172/JCI3054210.1172/JCI30542 ↗
50. 10.1016/j.jconrel.2019.04.02210.1016/j.jconrel.2019.04.022 ↗
51. 10.1038/s41467-019-14138-610.1038/s41467-019-14138-6 ↗